Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial

Affiliations

• ¹ Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
• ² LMC Diabetes and Endocrinology, Brampton, Ontario, Canada.
• ³ Academic Unit of Diabetes, Endocrinology and Metabolism, University of Sheffield, Sheffield, UK.
• ⁴ Novo Nordisk A/S, Søborg, Denmark.
• ⁵ Diabetes Research Centre, University of Leicester, Leicester, UK.
• ⁶ Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, California, USA.
• ⁷ Li Ka Shing Knowledge Institute, Division of Endocrinology & Metabolism, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
• ⁸ Scripps Whittier Diabetes Institute, La Jolla, California, USA.